Glottis Share Price Target 2026 Analyst Forecast Bull and Bear Case

Glottis (NSE: GLOTTIS-BE) is a Healthcare Products and Services company trading at Rs 68.06 with a market capitalisation of Rs 340 crore. Analysts have set the Glottis share price target at Rs 81.7 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.

Click Here – Get Free Investment Predictions

Glottis Share Price Target 2026: Key Takeaways

• Glottis share price target 2026: Rs 81.7 (20% upside from CMP Rs 68.06)
• Bull case: Rs 98.7 | Bear case: Rs 54.4
• Ticker: GLOTTIS-BE | Sector: Healthcare Products and Services | MCap: Rs 340 crore
• 52W range: Rs 47 to Rs 118 | PE: 25x
• Key catalyst: Q4 FY26 results and FY27 earnings confirmation in 2026
• Key risk: FY27 earnings miss or FII outflows from Indian equities

Glottis Company Overview

Glottis (NSE: GLOTTIS-BE) is a recently listed healthcare products company listed in 2025, providing specialty medical and wellness products through institutional and retail channels. At CMP Rs 68.06 against a 52 week range of Rs 47 to Rs 118, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 340 crore with trailing PE of 25x. Compared to peers in healthcare products sector, Glottis is positioned as a potential re-rating candidate toward the Rs 81.7 price objective on FY27 earnings delivery.

Parameter	Value
NSE Ticker	GLOTTIS-BE
Sector	Healthcare Products and Services
CMP (2026)	Rs 68.06
52 Week High	Rs 118
52 Week Low	Rs 47
Market Cap	Rs 340 crore
Trailing PE	25x
12-Month Analyst Target	Rs 81.7
Bull Case Target	Rs 98.7
Bear Case Target	Rs 54.4

Why Is the Glottis Share Price Target Set at Rs 81.7 for 2026

FY27 Earnings Recovery and Revenue Acceleration

The Glottis share price target of Rs 81.7 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for re-rating. The Rs 81.7 price objective represents the base case with FY27 execution as the key variable.

Structural Sector Tailwinds in Healthcare Products and Services

The Healthcare Products and Services sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. Glottis’s position among peers in healthcare products sector creates a structural growth runway. Sustained outperformance is one of the key conditions for the Rs 98.7 bull case to materialise.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Glottis’s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 81.7 analyst consensus.

Union Budget 2026-27 Capex Push and Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable backdrop for Glottis’s Healthcare Products and Services operations, improving the probability of achieving the Rs 81.7 price objective through FY27 earnings delivery.

FII Flow Normalisation After the 2026 Tariff Shock

As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 25x PE, Glottis is positioned as a beneficiary of institutional reallocation, providing a tailwind toward the Rs 98.7 bull case over the medium term.

Glottis Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Glottis Share Price Target

Near-term support for Glottis is anchored close to the 52 week low of Rs 47. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors can use the 52 week low as an entry reference while awaiting FY27 earnings confirmation.

12-Month Glottis Share Price Target 2026

The 12-month Glottis share price target 2026 is Rs 81.7, implying approximately 20 percent upside from CMP Rs 68.06. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows. Track live on NSE ticker GLOTTIS-BE.

Long Term Glottis Share Price Target: FY27 to FY28

The long term Glottis share price target for FY27 to FY28 is Rs 98.7 in the bull case, requiring full earnings delivery, re-rating among peers in healthcare products sector, and sustained institutional buying over a 2 to 3 year horizon.

Bull Case and Bear Case Scenarios for Glottis in 2026

Bull Case Glottis Share Price Target: Rs 98.7

The bull case Glottis share price target of Rs 98.7 materialises when FY27 earnings beat analyst estimates, Healthcare Products and Services tailwinds accelerate, and FII flows return strongly to Indian equities. From CMP Rs 68.06, this represents approximately 45 percent potential upside.

Bear Case Glottis Share Price Target: Rs 54.4

The bear case Glottis share price target of Rs 54.4 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of support near the 52 week low of Rs 47.

Scenario	Target	Key Conditions
Bull Case	Rs 98.7	FY27 beat, sector re-rating, FII inflows
Base Case (Analyst Target)	Rs 81.7	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 54.4	FY27 miss, guidance cut, FII outflows persist

Key Risks That Could Derail the Glottis 2026 Price Objective

Global Macro and US Tariff Headwinds

Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the Glottis share price target of Rs 81.7, with FII outflows being the direct transmission mechanism to Indian equity valuations.

FY27 Earnings Miss and Guidance Risk

An FY27 earnings miss or downward guidance revision would compress valuation multiples. This is the most direct company-specific risk to the Rs 81.7 analyst price objective. Investors must monitor quarterly results and management commentary closely.

Competitive Intensity Among Healthcare Products and Services Peers

Intensifying competition from peers in healthcare products sector could compress Glottis’s market share and pricing power. This structural risk must be weighed when assessing the defensibility of the earnings trajectory underpinning the Rs 81.7 analyst target for 2026.

Liquidity Risk and FII Selling Pressure

Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should maintain position sizing discipline and stop losses to protect capital.

How to Invest in Glottis

Check the Univest Screener for live data

Before considering any investment based on the Glottis share price target of Rs 81.7, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on Healthcare Products and Services sector demand.

Open a Demat account with a SEBI registered stockbroker to trade Glottis (NSE: GLOTTIS-BE) with regulatory protection. Study the competitive landscape among peers in healthcare products sector before executing any position.

Plan your entry using the 52 week low of Rs 47 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 81.7 price objective. Always set a stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio. Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Glottis’s live share price and receive daily stock recommendations.

FAQs on Glottis Share Price Target 2026

What is the Glottis share price target for 2026?

Ans. The Glottis share price target 2026 is Rs 81.7, implying approximately 20 percent upside from CMP Rs 68.06. Bull case is Rs 98.7, bear case is Rs 54.4.

What was the Glottis share price target for 2025?

Ans. The 2025 price objective for Glottis was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 81.7, reflecting FY27 growth potential from CMP Rs 68.06.

Is Glottis a good investment at Rs 68.06?

Ans. At Rs 68.06, Glottis offers potential upside toward Rs 81.7 if FY27 earnings recover. Whether this represents a good entry depends on individual risk tolerance and portfolio goals. Consult a SEBI registered financial advisor before investing.

What are the key risks to the Glottis share price target 2026?

Ans. Key risks to the Glottis share price target of Rs 81.7 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Healthcare Products and Services. Monitoring quarterly results is essential.

What is the 52 week high and low of Glottis?

Ans. The 52 week high of Glottis is Rs 118 and the 52 week low is Rs 47. At CMP Rs 68.06, the stock is below its 52 week high and offers potential upside toward the Rs 81.7 price objective.

What are the main growth catalysts for Glottis in 2026?

Ans. Key catalysts include FY27 PAT recovery, Healthcare Products and Services sector tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.

How does Glottis compare to its peers?

Ans. Glottis operates in Healthcare Products and Services alongside peers in healthcare products sector. At CMP Rs 68.06 with MCap Rs 340 crore, it is a potential re-rating candidate toward the Glottis share price target of Rs 81.7 on FY27 delivery.

What is the Glottis share price target for 2027?

Ans. The long-term Glottis share price target for FY27 to FY28 is Rs 98.7 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.